Cyber & Technology April 24, 2026 424 stories in this edition

US FDA plans ultra-fast review of 3 psychedelic drugs after Trump directive

SCMP Asia / Asia / 1m ago / Associated Press
US FDA plans ultra-fast review of 3 psychedelic drugs after Trump directive

Preview Brief

The Food and Drug Administration said on Friday it will offer ultra-fast review to three psychedelic drugs being developed to treat mental health conditions, including depression, the latest indication of the Trump administration’s commitment to the experimental treatment approach. President Donald Trump signed an executive order last weekend directing the FDA and other federal agencies to speed access and loosen res...

Feed Summary

The Food and Drug Administration said on Friday it will offer ultra-fast review to three psychedelic drugs being developed to treat mental health conditions, including depression, the latest indication of the Trump admin...

Related In Edition

More from Cyber & Technology

Related previews keep the same media frame and preserve your current desk context so you can continue scanning without losing the edition flow.